Hereditary angioedema caused by C1-esterase inhibitor deficiency: a case report with literature-based analysis
Keywords:C1-esterase inhibitor deficiency (HAE-C1-INH), CI inhibitor concentrate, Fresh frozen plasma (FFP), Hereditary angioedema (HAE), Plasma derived human C1 inhibitor concentrate (pdhC1INH), Pregnancy
Hereditary angioedema (HAE) caused by C1-esterase inhibitor deficiency is an autosomal-dominant disease caused by a mutation in the C1-inhibitor gene. It is a rare disease that is often worsened during pregnancy and childbirth. HAE, though uncommon but if untreated it may lead to maternal death. The case report presents the successful management of a 24 years old, G2P1, with hereditary angioedema caused by C1-esterase inhibitor deficiency. This patient was managed with a multidisciplinary approach by an obstetrician, an immunologist, an anaesthesiologist and a pediatrician. She had an uneventful antenatal period, labor was induced. She had precipitate delivery and soon after delivery had a flare up of the disease. It was successfully managed with fresh frozen plasma and close observation.
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-74.
Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Heller C, Klingebiel T, Kreuz W. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol. 2010;203(2):131-e1.
Atsushi S, Takayuki F, Tomohiro N. Comparison of the frequency of angioedema attack, before and during pregnancy, in a patient with type i hereditary angioedema. Intern Med. 2018;57:751-5.
Riedl MA, Banerji A, Gower R. Current medical management of hereditary angioedema: follow-up survey of US physicians. J Allerg Clin Immunol Pract. 2015;3:220-7.
Chen M, Riedl MA. Emerging Therapies in Hereditary Angioedema. Immunol Allerg Clin. 2017;37(3):585-95.
Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, et al. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allerg Clinic Immunol. 2012;129(2):308-20.
Ushijima J, Sasaki S, Horiuchi I, Masuko H, Kuwata T. A Case of Pregnancy Complicated with Type 1 Hereditary Angioedema (HAE 1). J Clin Case Rep. 2017;7(924):2.
Cimbollek S, López-Serrano MC, Piñero-Saavedra M, Rubio M, Caballero T. Management of pregnancy and delivery in patients with hereditary angioedema due to C1 inhibitor deficiency. J Investig Allergol Clin Immunol. 2016;26(3).
Moldovan D, Bernstein JA, Hakl R, Relan A. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks in pregnant women. J Allerg Clinic Immunol. 2018;141(2):AB53.
Teresa C, Julio C, Daniela RP, Rosario C. Management of hereditary angioedema in pregnant women: a review. Int J Women’s Heal. 2014;6:839-48.
Maurer M, Magerl M, Ansotegui I, Aygören-Pürsün E, Betschel S, Bork K, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-the 2017 revision and update. World Allerg Organizat J. 2018;11(1):5.
Mosier M, Riddle JD. Prophylaxis and Treatment of Hereditary Angioedema with Fresh Frozen Plasma: A Synthesis and Narrative Review. Anesthesia E J. 2018;6:12-7.
Green L, Bolton‐Maggs P, Beattie C, Cardigan R, Kallis Y, Stanworth SJ, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Brit J Haematol. 2018;181(1):54-67.
Aleena B, Marc R. Managing the Female Patient with Hereditary Angioedema. Womens Health. 2016;12
Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema Int Working Group. Allergy. 2014;69(5):602-16.